9Q26 image
Deposition Date 2025-08-14
Release Date 2026-07-01
Last Version Date 2026-07-01
Entry Detail
PDB ID:
9Q26
Title:
Structure of the Measles virus Fusion glycoprotein ectodomain in complex with two neutralizing antibodies 4F09 and 3A12
Biological Source:
Source Organism(s):
Method Details:
Experimental Method:
Resolution:
2.30 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Fusion glycoprotein F1
Gene (Uniprot):F
Mutagens:E170G, E455G
Chain IDs:N (auth: A), P (auth: B), R (auth: C)
Chain Length:112
Number of Molecules:3
Biological Source:Measles morbillivirus
Protein Blast
Polymer Type:polypeptide(L)
Molecule:3A12 Fab Heavy chain
Chain IDs:A (auth: D), E (auth: H), I (auth: L)
Chain Length:252
Number of Molecules:3
Biological Source:Homo sapiens
Protein Blast
Polymer Type:polypeptide(L)
Molecule:3A12 Fab Light chain
Chain IDs:B (auth: E), F (auth: I), J (auth: M)
Chain Length:236
Number of Molecules:3
Biological Source:Homo sapiens
Protein Blast
Polymer Type:polypeptide(L)
Molecule:4F09 Fab Heavy chain
Chain IDs:C (auth: F), G (auth: J), K (auth: N)
Chain Length:259
Number of Molecules:3
Biological Source:Homo sapiens
Protein Blast
Polymer Type:polypeptide(L)
Molecule:4F09 Fab Light Chain
Chain IDs:D (auth: G), H (auth: K), L (auth: O)
Chain Length:236
Number of Molecules:3
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Fusion glycoprotein F2
Gene (Uniprot):F
Chain IDs:M (auth: a), O (auth: b), Q (auth: c)
Chain Length:112
Number of Molecules:3
Biological Source:Measles morbillivirus
Ligand Molecules
Primary Citation
Human neutralizing antibodies targeting the measles virus hemagglutinin and fusion surface proteins.
Cell Host Microbe 34 1067 1081.e12 (2026)
PMID: 42102820 DOI: 10.1016/j.chom.2026.04.010

Abstact

Measles virus (MeV), a highly transmissible paramyxovirus, can cause severe complications and death, particularly in infants and young children. How and where human antibodies target and neutralize MeV remain unclear. Here, we report a panel of human monoclonal antibodies (mAbs) specific for MeV hemagglutinin (H) and fusion (F) surface proteins, derived from the memory B cells of a Measles-Mumps-Rubella (MMR) vaccinee. We mapped four and five major epitope clusters on H and F, respectively, and structurally characterized representative mAbs from each epitope cluster. MAbs against both H and F offer broad, potent, picomolar-level neutralization and substantially reduce viral loads in vivo when delivered before or after viral exposure. High-resolution cryo-electron microscopy of mAb complexes with H and F reveal highly conserved contact sites of the most protective antibodies. Characterization of these fully human mAbs provides avenues for prophylactic or therapeutic intervention against re-emerging MeV.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback